We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

GLOBE SCIENTIFIC

Globe Scientific, Inc. is an ISO 9001:2015 certified worldwide supplier of high-quality laboratory plasticware, glass... read more Featured Products: More products

Download Mobile App




Globe Scientific Introduces New Enhanced & Portable Clinical Centrifuges

By LabMedica International staff writers
Posted on 03 Aug 2022

Globe Scientific, Inc. More...

(Mahwah, NJ, USA) has introduced two new centrifuges to expand on its successful range of benchtop laboratory equipment. The expansion adds a new GCC-P portable clinical centrifuge as well as a new GCC-E50 which allows for spins of 50mL centrifuge tubes at an economical cost.

The GCC-P portable clinical centrifuge is designed for easy transport to facilitate convenient field separations using the included 12VDC car power adapter. It is compact in size and packed with the features required for routine clinical applications. The included six-position rotor accommodates 1.5mL to 5mL, 7mL, 10mL and 15mL tubes (all adapters are included). A weighted base ensures the unit remains stable in field environments. An easy-to-read LCD display shows both time and speed or RCF. Two program buttons enable simple programming and recall of regularly used methods. The timer will not count down until the set speed is reached to ensure your separations and experiments work as intended. Safety is maintained by an automatic lid lock that only disengages when the program is completed or manually once the unit has completely stopped.

Globe Scientific’s GCC-E50 enhanced clinical centrifuge is an economical solution for 15mL and 50mL separations with an enhanced user interface, easy to read backlit LCD display, tight accuracy, and automated self-diagnostics on startup. An extension based on the company’s GCC-E enhanced clinical centrifuge, the GCC-E50 employs a new rotor for spinning up to six 50mL centrifuge tubes or six 15mL centrifuge tubes.

Related Links:
Globe Scientific, Inc. 


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
New
Microbiology Laboratory Automation Solution
BD Kiestra™ ReadA+BarcodA
All-in-One Molecular System
AIO M160
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: A large, international study led by City of Hope found that the new, investigational liquid biopsy, called PANXEON, was highly sensitive in detecting stage 1 and 2 pancreatic cancer and had a low rate of false positives. The test was also able to identify high-grade dysplasia, a precancerous condition of the pancreas, potentially enabling intervention before cancer develops. (Photo courtesy of City of Hope)

Multi-Biomarker Blood Test Shows Promise for Early Pancreatic Cancer Detection

Pancreatic cancer has the lowest survival rates of any cancer, with only 14% of patients alive five years after diagnosis. The disease is typically discovered after it has spread, and an estimated 90%... Read more

Microbiology

view channel
Image: Graphical Abstract (Jose A. Céspedes, Maria I. Montañez, Isabel M. Jiménez, et al. Magnetic nanoparticles enable clinically relevant in vitro diagnosis of beta-lactam allergy. Materials Today Bio (2026). DOI: 10.1016/j.mtbio.2026.103356)

Magnetic Nanoparticles Enable More Sensitive Beta-Lactam Allergy Testing

Penicillin allergy labels are common in clinical practice, yet many are incorrect and can lead to suboptimal antibiotic choices. Although 8%–25% of people report a penicillin allergy, only 1%–10% are truly... Read more

Technology

view channel
Image: Graphical Abstract (Wenjie Zhang, Zeyu Luo, Kaijie Liu, et al. Science Bulletin, 2026. doi:10.1016/j.scib.2026.09.016)

Multimodal AI Framework Aims to Guide Cancer Immunotherapy Decisions

Cancer immunotherapy has reshaped oncology, but heterogeneous responses and immune-related toxicities continue to complicate routine decision-making. Standard biomarkers, including programmed death-ligand... Read more

Industry

view channel
Image: The acquisition adds Convergent Genomics’ UroAmp platform and proprietary urinary tumor DNA technology to Veracyte’s portfolio (Photo courtesy of Convergent Genomics)

Veracyte Acquisition Expands Urine-Based Bladder Cancer Monitoring Capabilities

Veracyte, Inc. has acquired Convergent Genomics, expanding its urology diagnostics offerings with the company’s UroAmp platform and proprietary urinary tumor DNA (utDNA) technology. UroAmp has been clinically... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.